AML

Results: 1283



#Item
441Chemistry / Measuring instruments / Wire / Sensors / Thermometers / Thermocouple / Polyimide / Alumel / Copper wire and cable / Electromagnetism / Technology / Dielectrics

ARUN MICROELECTRONICS LTD. AML DATA SHEET: KW Issue C UHV-COMPATIBLE WIRE AND THERMOCOUPLES KW3, KW6, KW9 and KTK

Add to Reading List

Source URL: www.tectra.de

Language: English - Date: 2011-11-24 04:48:34
442Privacy / Data privacy / Freedom of information legislation / Policy / Privacy policy / Internet privacy / Information privacy / Freedom of Information Act / Right to Information Act / Privacy law / Ethics / Law

Privacy fact sheet 17 Australian Privacy Principles February 2013 From 12 March 2014, the Australian Privacy Principles (APPs) will replace the National Privacy Principles and Information Privacy Principles and will appl

Add to Reading List

Source URL: aml.com.au

Language: English - Date: 2014-01-23 23:25:28
443Computing / Marketing / Email marketing / Email spam / Electronic mailing list / Opt-out / Opt in email / Spam Act / Spam / Spamming / Email / Internet

Email Marketing Compliance Fact Sheet Permission-based email marketing is used effectively everyday by many organisations to build their brands, increase sales, and strengthen relationships with their customers. Permissi

Add to Reading List

Source URL: aml.com.au

Language: English - Date: 2013-10-02 02:19:14
444Biomarker / Medicine / Astex / Acute myeloid leukemia

September 30, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a ph

Add to Reading List

Source URL: astx.com

Language: English
445Leukemia / Epigenetics / Biology / Myelodysplastic syndrome / Syndromes / Acute myeloid leukemia

SuperGen Announces Enrollment of First Patient in First in Human Trial of SGI-110 in MDS and AML Patients DUBLIN, Calif., Jan 05, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG) today announced that it has enrolled th

Add to Reading List

Source URL: astx.com

Language: English
446Acute leukemia / Acute myeloid leukemia / Myeloid leukemia / Design of experiments / Myelodysplastic syndrome / Clinical trial / Medicine / Health / Clinical research

December 10, 2012 Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2 MDS and AML Study in an Oral Presentation at ASH DUBLIN, Calif., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceu

Add to Reading List

Source URL: astx.com

Language: English
447Acute myeloid leukemia / Myeloid leukemia / Clinical research / Design of experiments / Myelodysplastic syndrome / Astex / Clinical trial / Medicine / Health / Acute leukemia

June 22, 2012 Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasd

Add to Reading List

Source URL: astx.com

Language: English
448Syndromes / Acute myeloid leukemia / Leukemia / Neutropenia / Thrombocytopenia / Decitabine / Medicine / Oncology / Myelodysplastic syndrome

Astex Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the

Add to Reading List

Source URL: astx.com

Language: English
449Generally Accepted Accounting Principles / Taxation / Financial statements / Financial accounting / Financial markets / Balance sheet / Income tax in the United States / Deferral / Income tax / Finance / Accountancy / Business

October 30, 2012 Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results Dacogen Approved in the European Union for the Treatment of Elderly AML Initiated HSP90 Inhibitor AT13387 Clinical Trials in Prostate &

Add to Reading List

Source URL: astx.com

Language: English
450Astex / Leukemia / Acute leukemia / Myeloid leukemia / Acute myeloid leukemia

August 28, 2013 Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study SGI-110 Phase 2 Shows Clear Activity in Patients With Acute Myeloid Leukemia DUBLIN, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) --

Add to Reading List

Source URL: astx.com

Language: English
UPDATE